Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahmoud Aljurf

Showing results (131-140 of 403) with videos related to

Pageof 41
Sort By:
Haematologica|September 21, 2010
Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donorsVikas Gupta, Mary Eapen, Ruta Brazauskas, et al.
Blood|April 26, 2003
Stem cell transplantation for chronic myeloid leukemia in childrenKate Cwynarski, Irene A G Roberts, Simona Iacobelli, et al.
Haematologica|August 16, 2019
Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin <i>versus</i> allogeneic bone marrow transplantation without anti-thymocyte globulinFrédéric Baron, Jacques-Emmanue Galimard, Myriam Labopin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 10, 2015
HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant ResearchMichael R Verneris, Stephanie J Lee, Kwang Woo Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 19, 2019
Role of Physical Therapy before and after Hematopoietic Stem Cell Transplantation: White Paper ReportJaleel Mohammed, Sean R Smith, Linda Burns, et al.
Blood|May 3, 2013
The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donorsCarolyn Katovich Hurley, Ann Woolfrey, Tao Wang, et al.
Transplantation and Cellular Therapy|June 29, 2026
Reduced-dose post-transplant cyclophosphamide as graft-versus-host disease prophylaxis in matched donor allogeneic stem cell transplantation: a systematic review of efficacy and toxicityAreez Shafqat, Malaz El-Sibai, Abdulrahman Nasiri, et al.
Haematologica|February 9, 2012
Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groupsAndrea Bacigalupo, Gérard Socié, Hubert Schrezenmeier, et al.
Journal of Hematology & Oncology|October 25, 2019
Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMTJiří Pavlů, Myriam Labopin, Riitta Niittyvuopio, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 5, 2019
Improved Outcome of a Pediatric-Inspired Protocol for High-Risk Adolescent and Young Adult Acute Lymphoblastic Leukemia Patients Using Peg-Asparaginase and Escalating Dose of Methotrexate: Tolerability and OutcomeAmr Hanbali, Ahmed Kotb, Riad El Fakih, et al.
Pageof 41

Showing results (131-140 of 403) with videos related to

Sort By:
Pageof 41
Haematologica|September 21, 2010
Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donorsVikas Gupta, Mary Eapen, Ruta Brazauskas, et al.
Blood|April 26, 2003
Stem cell transplantation for chronic myeloid leukemia in childrenKate Cwynarski, Irene A G Roberts, Simona Iacobelli, et al.
Haematologica|August 16, 2019
Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin <i>versus</i> allogeneic bone marrow transplantation without anti-thymocyte globulinFrédéric Baron, Jacques-Emmanue Galimard, Myriam Labopin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 10, 2015
HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant ResearchMichael R Verneris, Stephanie J Lee, Kwang Woo Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 19, 2019
Role of Physical Therapy before and after Hematopoietic Stem Cell Transplantation: White Paper ReportJaleel Mohammed, Sean R Smith, Linda Burns, et al.
Blood|May 3, 2013
The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donorsCarolyn Katovich Hurley, Ann Woolfrey, Tao Wang, et al.
Transplantation and Cellular Therapy|June 29, 2026
Reduced-dose post-transplant cyclophosphamide as graft-versus-host disease prophylaxis in matched donor allogeneic stem cell transplantation: a systematic review of efficacy and toxicityAreez Shafqat, Malaz El-Sibai, Abdulrahman Nasiri, et al.
Haematologica|February 9, 2012
Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groupsAndrea Bacigalupo, Gérard Socié, Hubert Schrezenmeier, et al.
Journal of Hematology & Oncology|October 25, 2019
Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMTJiří Pavlů, Myriam Labopin, Riitta Niittyvuopio, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 5, 2019
Improved Outcome of a Pediatric-Inspired Protocol for High-Risk Adolescent and Young Adult Acute Lymphoblastic Leukemia Patients Using Peg-Asparaginase and Escalating Dose of Methotrexate: Tolerability and OutcomeAmr Hanbali, Ahmed Kotb, Riad El Fakih, et al.
Pageof 41